Fortis Healthcare has secured a favorable ruling from the Delhi High Court in a civil suit filed against a third party and others. The court's order dated December 19, 2025, decided the case in favor of the company, granting permanent injunction against the third party's actions and upholding the company's challenge to their locus.

Background of the Legal Dispute

The legal proceedings stem from events that occurred in the year ended March 31, 2023. A party claiming to be an assignee of a third party initiated arbitration proceedings against Fortis Healthcare. During these proceedings, an ex-parte interim award was passed, which was subsequently terminated by the arbitrator.

The company disclosed that it neither received any notice nor any statement of claim regarding the arbitration proceedings. In response to these developments, Fortis Healthcare filed a civil suit challenging the locus of the said parties and seeking permanent injunction against their actions.

Court Ruling Details

The following table summarizes the key aspects of the legal settlement:

Financial Impact Assessment

Fortis Healthcare has confirmed that the settlement will have no impact on the company's financial position. The company stated that no compensation or penalty was paid as part of this resolution, and the terms of settlement are not applicable given the nature of the court's ruling in their favor.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company formally notified the stock exchanges on December 23, 2025, at 12:33 p.m., ensuring compliance with regulatory requirements for material event disclosures.

This legal victory provides clarity on the disputed matter and removes any potential uncertainty that may have surrounded the arbitration proceedings initiated against the company.

Fortis Healthcare Limited has completed annual interest payments totaling ₹130.47 crores to its debenture holders on December 22, 2025. The healthcare major fulfilled its regulatory obligations under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Interest Payment Details

The company made payments across three separate debenture series to institutional investors. The interest payments were distributed among major financial institutions as detailed below:

Payment Schedule and Compliance

The interest payment process followed the established timeline with specific dates for record and payment:

The payment date was adjusted from December 20 to December 22, 2025, as the original due date fell on a Saturday, which is not a business day. According to the Key Information Document provisions, when coupon payment dates fall on non-business days, interest becomes payable on the immediately succeeding business day.

Debenture Portfolio Overview

The three debenture series represent a combined principal amount of ₹1,550 crores distributed as follows:

All three series follow an annual interest payment frequency, with no changes reported in the payment structure. The company confirmed that no redemption payments were due during this period, and there were no delays or issues in the interest payment process.

Regulatory Compliance

Fortis Healthcare's timely completion of these interest payments demonstrates adherence to its debt obligations and regulatory compliance under SEBI guidelines. The company secretary and compliance officer, Satyendra Chauhan, certified the completion of all required payments to the respective debenture holders as scheduled. The certificate was filed pursuant to Regulation 57 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.